Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. <i>Antibiotics</i> 2021, <i>10</i>, 649
1.1 Based on the initial data from Table 1 there were errors in the original article [...]
Saved in:
Main Authors: | Christina König (Author), Anna Both (Author), Holger Rohde (Author), Stefan Kluge (Author), Otto R. Frey (Author), Anka C. Röhr (Author), Dominic Wichmann (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
by: Christina König, et al.
Published: (2021) -
Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Cefiderocol
by: Julia Zimmer, et al.
Published: (2021) -
Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023) -
Challenges Facing Two Outbreaks of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: From Cefiderocol Susceptibility Testing to the Emergence of Cefiderocol-Resistant Mutants
by: Montserrat Rodríguez-Aguirregabiria, et al.
Published: (2024) -
In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Isolates
by: Harald Seifert, et al.
Published: (2023)